Superior Planning, LLC’s Medline Inc MDLN Stock Holding History

Superior Planning, LLC’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$12.1K	Buy	+350	New	+$12.8K	0.01%	862

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return

H&F Corporate Investors X San Francisco, California $2.46B AUM 15.37% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Egerton Capital (UK) London, United Kingdom $9.8B AUM 22.76% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Superior Planning, LLC's MDLN Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Medline Inc (MDLN) in Q3 2026: 350 shares worth $12.1K. The stake represents 0.01% of the portfolio and ranks #862 among its holdings.

261 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

Superior Planning, LLC held 350 shares of Medline Inc worth $12.1K as of Q3 2026.
Medline Inc was a new Superior Planning, LLC position in Q3 2026.
Medline Inc made up 0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #862 holding.
261 funds tracked by Wall St. Rank held Medline Inc as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.